Recent Financing
Recent Raise
Arthrosi Therapeutics is a late-stage biotech developing pozdeutinurad, a highly selective URAT1 inhibitor aimed at reducing serum urate levels and resolving flares and tophi in gout patients.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Arthrosi Therapeutics.
